Updates From Angiogenesis 2021
These podcasts are an editorially independent initiative with support by Roche. To learn more about Roche Ophthalmology, visit www.futureofvision.global
Updates from Angiogenesis 2021: Neovascular AMD
Presented by:
Charles C. Wykoff, MD, PhD
Jeffrey Heier, MD
Charles C. Wykoff, MD, PhD,
Associate Professor of Clinical Ophthalmology, Academic Institute
Associate Clinical Member, Research Institute
Houston Methodist
Weill Cornell Medical College
Dr. Wykoff has written and published over 120 peer-reviewed scientific manuscripts, book chapters, national meeting presentations and abstracts. Dr. Wykoff 's interests pertain to angiogenesis and retinal vascular diseases including age-related macular degeneration, diabetic retinopathy, and venous occlusive diseases, as well as vitreoretinal surgery topics such as retinal detachment and macular surgery.
Jeffrey Heier, MD
Co-President and Medical Director,
Director of the Vitreoretinal Service,
and Director if Retina Research at Ophthalmic Consultants of Boston
Dr. Heier is on the Executive Board of the Retina Society, on the Executive Committee of the American Society of Retinal Specialists, and a member of the Macula Society. He has authored or co-authored over 100 works in peer-reviewed journals, as well as served as a reviewer for the New England Journal of Medicine, Lancet, Ophthalmology, Archives of Ophthalmology, American Journal of Ophthalmology, Retina, and numerous other journals.
Updates from Angiogenesis 2021: Diabetic Eye Disease
Presented by:
Jennifer Sun, MD, MPH
David S. Boyer, MD
Jennifer Sun, MD, MPH,
Associate Professor of Ophthalmology, Harvard University Medical School
Chief of the Center for Clinical Eye Research
and Trials of the Beetham Eye Institute, Joslin Diabetes Center
In addition to her academic appointments, Dr. Sun serves as the Chair for the Diabetic Retinopathy Clinical Research Retina Network (DRCR.net) and has chaired multiple nationwide, multicenter studies addressing new treatments and methods of evaluation for diabetic eye disease.
David S. Boyer, MD
Senior Partner at Retina-Vitreous Associates Medical Group in Calif.
Adjunct Clinical Professor of Ophthalmology with the University of Southern California/Keck School of Medicine in Los Angeles, CA
Dr. Boyer is a world-renowned retina specialist and is currently a leading investigator for various national clinical trials on retinal diseases. Dr. Brown serves as an advisor for multiple research, educational and charitable institutions.
Updates from Angiogenesis 2021: Gene Therapy
Presented by:
Arshad M. Khanani, MD
David M. Brown, MD
Arshad M. Khanani, MD
Clinical Associate Professor, University of Nevada, Reno
Managing Partner, Director of Clinical Research, Sierra Eye Associates
Dr. Khanani is a fellowship trained vitreo-retinal specialist and is certified by The American Board of Ophthalmology. Dr. Khanani has served as a principal investigator for several clinical trials. His articles have been published in numerous ophthalmology journals. Dr. Khanani has received numerous awards of distinction including The Patients’ Choice Award and The Compassionate Doctor Recognition Award. He has also been consistently named one of America’s Top Ophthalmologists.
David M. Brown, MD
Partner at Retina Consultants of Texas
Coordinator, Retina Consultants of America
Dr. Brown has more than 300 scientific papers and abstracts written on retinal diseases and has continuously been recognized as one of the "Best Doctors in America" from 2007 – 2018. He has received the honor as one of the "Texas Super Docs" from 2009 – 2018. Dr. Brown serves as the consultant retina specialist for NASA for all ongoing and long-term space flight astronauts.
